Morepen Laboratories Limited (NSE:MOREPENLAB)

India · Delayed Price · Currency is INR

35.45

-1.75 (-4.70%)

Apr 2, 2026, 10:40 AM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Business	18.12B	16.90B	14.22B	15.56B	11.98B
Pharmaceutical Business Growth	7.17%	18.88%	-8.60%	29.87%	39.57%
Total	18.12B	16.90B	14.22B	15.56B	11.98B
Total Growth	7.17%	18.88%	-8.60%	29.87%	39.57%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
United States of America	1.21B	1.57B	879.38M	1.01B	680.00M
United States of America Growth	-23.32%	79.02%	-12.63%	48.02%	35.25%
Rest of World	5.90B	4.82B	4.76B	4.58B	4.09B
Rest of World Growth	22.28%	1.28%	3.90%	12.13%	39.49%
India	10.93B	10.43B	8.50B	9.83B	6.99B
India Growth	4.88%	22.66%	-13.51%	40.64%	40.77%
Total	18.04B	16.82B	14.14B	15.42B	11.75B
Total Growth	7.23%	18.97%	-8.28%	31.16%	39.99%

Source: S&P Global Market Intelligence.